An article by Jessica von Reyn “Patent Term Extension: Challenges with Defining and Claiming Approved Biologics” was published in Pharmaceutical Executive®. As biologics continue to transform modern t...
John Welch co-authored the January-February 2026 edition of The Trademark Reporter, The Law Journal of The International Trademark Association (INTA). Titled “United States Annual Review: The Seventy-...
Introduction For in-house counsel, IP due diligence is not simply a checklist exercise—it is a real-time test of the company’s long-term intellectual property strategy. With transaction timelines ofte...
An article by Matt Grady titled “AI as a Bridge Between In-House and Outside Counsel” was published in Managing IP. As AI adoption accelerates across legal departments, it offers meaningful efficienci...
Patent owners have significant leverage at the negotiating table, but that leverage has limits. In various circumstances, the Supreme Court has held that while a patentee may refuse to license its inv...
This past year saw major shifts affecting patent adjudication, prosecution strategy, biotechnology claiming, artificial intelligence, standard-essential patents, and litigation trends. Moving into 202...
I. Introduction Artificial intelligence, particularly generative AI (GAI), has become an increasingly important component of modern legal practice. Whether you are in-house counsel, outside counsel, o...
A column authored by Jason Balich titled “Avoiding the ‘Atomic Bomb of Patent Law’” was published in the American Institute of Chemical Engineers’ Chemical Engineering Progress (CEP) Magazine. In this...
The US Patent and Trademark Office (USPTO) is navigating a period of significant transition. Driven by workforce shifts, operational restructuring, evolving approaches to subject matter eligibility, a...
Whether you are in-house, outside counsel, a solo practitioner, or working alongside any of these teams, you should be aware of the duty to use artificial intelligence (AI) responsibly, ethically, and...
An article by Maria Crusey and Ed Russavage titled “Procedural Implications of Multidistrict AI Copyright Infringement Lawsuits” was published in Managing IP. As of November 21 2025, more than 50 laws...
In the United States, medical device regulation and intellectual property (IP) protection are governed by complex statutory and regulatory frameworks that are distinct from—but closely related to, and...